METHOD FOR CHOOSING MANAGEMENT TACTICS FOR PATIENTS AFTER CORONAVIRUS INFECTION COVID-19 IN ORDER TO PREVENT LONG-TERM THROMBOTIC COMPLICATIONS Russian patent published in 2022 - IPC G01N33/50 A61B5/00 A61P31/14 A61K31/166 

FIELD: medicine.

SUBSTANCE: invention relates to medicine and concerns a method for choosing the tactics of managing patients after a coronavirus infection COVID-19 in order to prevent long-term thrombotic complications, including the study of the von Willebrand factor (vFW), where a patient receiving rivaxoban after discharge from the hospital undergoes a study of vFW for 1- 3 days before the end of taking rivaxoban, if vFW is 1.3 times or more higher than the upper limit of normal, prolong rivaxoban for another 30 days, and if less, cancel.

EFFECT: invention provides an expansion of the arsenal of technical means that provide a differentiated approach to the choice of tactics for managing patients after suffering a coronavirus infection COVID-19; allows you to make an informed decision on the prolongation of the use of DOACs for the prevention of thrombotic complications.

1 cl, 3 ex